DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION

Acarix AB (publ)

OTCPK:ACIX.F Stock Report

Market Cap: US$27.5m

  • Company Overview
    • Valuation
    • Future Growth
    • Past Performance
    • Financial Health
    • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

Acarix Management

Management criteria checks 3/4

Acarix's CEO is Aamir Mahmood, appointed in Feb 2024, has a tenure of 2.58 years. total yearly compensation is SEK4.82M, comprised of 94% salary and 6% bonuses, including company stock and options. directly owns 0.88% of the company’s shares, worth $242.14K. The average tenure of the management team and the board of directors is 2.1 years and 2.5 years respectively.

Key information

Aamir Mahmood

Chief executive officer

SEK 4.8m

Total compensation

CEO salary percentage94.01%
CEO tenure2.6yrs
CEO ownership0.9%
Management average tenure2.1yrs
Board average tenure2.5yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Aamir Mahmood's remuneration changed compared to Acarix's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2026n/an/a

-SEK 39m

Mar 31 2026n/an/a

-SEK 43m

Dec 31 2025SEK 5mSEK 5m

-SEK 48m

Sep 30 2025n/an/a

-SEK 52m

Jun 30 2025n/an/a

-SEK 62m

Mar 31 2025n/an/a

-SEK 65m

Dec 31 2024SEK 6mSEK 5m

-SEK 66m

Compensation vs Market: Aamir's total compensation ($USD496.95K) is about average for companies of similar size in the US market ($USD652.98K).

Compensation vs Earnings: Aamir's compensation has been consistent with company performance over the past year.


CEO

Aamir Mahmood (50 yo)

2.6yrs
Tenure
SEK 4,823,000
Compensation

Mr. Aamir Mahmood serves as President and Chief Executive Officer of Acarix AB (publ) since February 1, 2024. He serves as General Manager/Vice President Americas of MicroPort CRM. He has experience in cor...


Leadership Team

NamePositionTenureCompensationOwnership
Aamir Mahmood
President & CEO2.6yrsSEK 4.82m0.88%
$ 242.1k
Christian Lindholm
CFO & Executive VP10.7yrsSEK 2.28m0.027%
$ 7.5k
Carma Connely
Head of Operations & Customer Excellenceno datano datano data
Andrew Turk
Director of Salesless than a yearno datano data
George Chrysant
Chief Medical Advisor2.7yrsno data0.12%
$ 33.3k
Jeffrey Rudd
Head of US Finance1.7yrsno datano data
Beji George
Head of Global Strategy & Therapy Development1.7yrsno datano data
2.1yrs
Average Tenure
50yo
Average Age

Experienced Management: ACIX.F's management team is considered experienced (2.1 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Erik von Schenck
Directorless than a yearno datano data
Kenneth Nelson
Independent Director & Member of the Advisory Board2.6yrsSEK 695.00kno data
David Erlinge
Member of Clinical Advisory Boardno datano datano data
Marcin Golebicki
Directorless than a yearno datano data
Morten Bottcher
Member of Clinical Advisory Boardno datano datano data
Peter Clemmensen
Member of Clinical Advisory Boardno datano datano data
John Cleland
Member of Clinical Advisory Boardno datano datano data
Deepak Talreja
Medical Advisor3.1yrsno datano data
Saumil Oza
Member of the Advisory Board2.6yrsno datano data
Dave Braun
Member of the Advisory Board2.6yrsno datano data
Jan Poulsen
Chairman of Board1.3yrsSEK 411.00k3.44%
$ 946.2k
Tony Das
Independent Director2.3yrsSEK 394.00k0.16%
$ 44.4k
2.5yrs
Average Tenure
62yo
Average Age

Experienced Board: ACIX.F's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/13 01:15
End of Day Share Price 2026/09/02 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Acarix AB (publ) is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
John SavinEdison Investment Research
Ludvig SvenssonRedeye
Filip EinarssonRedeye

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide